Preoperative induction chemotherapy for resectable stage IIIA non-small-cell lung cancer: A meta-analysis of 13 double-blind, randomized clinical trials

Chinese Journal of Lung Cancer

Volumn 11, Issue 3, 2008, Pages 398-405

  Dai, Yun ^a   Han, Baohui ^a   Shen, Jie ^a   Qi, Dajiang ^a   Jiang, Liyan ^a   Gu, Jianqing ^a   Chu, Tianqing ^a   Dong, Yu ^a   Shi, Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemotherapy; Lung neoplasms; Meta analysis

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 47149098815     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.03.020     Document Type: Article

References (23)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 1995, 311(7010): 889-890.
2. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement, 1996, 276 (8): 637-639.
3. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 1998, 17(24): 2815-2834
4. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50(4): 1088-1101.
5. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109): 629-634.
6. Dautzenberg B, Benichou J, Allard P, et al. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial. Cancer, 1990, 65(11): 2435-2441.
7. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg, 1992, 53 (6): 992-998.
8. Roth JA, Fosella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst, 1994, 86(9): 673-680.
9. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. Lung Cancer, 1998, 21(1): 1-6.
10. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med, 1994, 330 (3): 153-158.
11. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIa non-small cell lung cancer: A 7 year assessment of a randomized controlled trial. Lung Cancer, 1999, 26(1): 7-14.
12. Zhou QH, Liu IX, Li lu, et al. A random clinical trial of preoperative neoadjuvmlt chemotherapy followed by surgery in the treatment of stage III non-small cell lung cancer. Chin J Lung Cancer, 2001, 4(4): 251-256.
13. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except TINO), II and IIIa non-small cell lung cancer. J Clin Oncol. 2002, 20(1): 247-253.
14. Nagai K, Tsuchiya R, Mori T, et al. A randomised trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIa N2 non-small cell lung cancer. J Thorac Cardiovase Surg, 2003, 125(2): 254-260.
15. Li Q, Song YH, Zheng ZY, et al. Clinical Evaluation of Preoperative Short course Chemotherapy in Treatment of Stage III Non-small Cell Lung Cancer. Chin J Cancer Prev Treat, 2003, 10(5): 505-507.
16. Liao MI, Zhou YZ, Ding JA, et al. The study of perioperative chenmotrerapy in stage I-IIIa NSCLC. Ntal Med J Chin, 2003, 83(11): 962-966.
17. Yao Ke, Xiang MZ, Min JX, el al. A Randomized Clinical Trial of Preoperative Neoadjuvant Chemotherapy in the Treatment of Stage III Non-small Cell Lung Cancer. J Clin Oncol China, 2004, 31(11): 611-613.
18. Sorensen JB, Riska H, Ravn J, et al. Scandinavian phase III trial of neoadjuvant chemotherapy in NSCLC stages IB-IIIA/T3. Proc Am Soc Clin Oncol, 2005, 23(16): 7146 (Abstract).
19. Pisters K, Vallieres E, Bunn P, et al. S9900: A phase III trial of surgery alone or surgery plus pre-operative (pre-op) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Proc Am Soc Clin Oncol, 2007, 25(18): 7520 (Abstract).
20. Gilligan D, Nicolson M, Smith I, et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet, 2007, 369(9577): 1929-1937.
21. Nakamura H, Kawasaki N, Taguchi M, et al. Role of preoperative chemotherapy for non-small-cell lung cancer: A meta-analysis. Lung cancer, 2006, 54(3): 325-329.
22. Felip, R. Rosell, B. Massuti, et al. The NATCH trial: observations on the neoadjuvant arm. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I, 2007, 25(18): 7578.
23. Scagliotti GV on behalf of Ch.E.S.T. Investigators. Preliminary results of Ch.E.S.T.: A phase III study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol, 2005, 23(16): 7023 (Abstract).